CSIMarket Company Name, Ticker, Competitors, else..
 
Inhibikase Therapeutics Inc   (NASDAQ: IKT)
 

IKT's Market share relative to its competitors, as of Q2 2026

As of Q2 2026 (Revenue in Millions of $)

Date modified: 2026-05-13T21:56:30+00:00




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

COMPANY NAME REVENUES
12 Months Ending
Q2 2026		 MARKET SHARE
12 Months
Q2 2026		 MARKET SHARE
MRQ
Q2 2026		 MARKET SHARE
A Quarter Before
Q1 2026
Inhibikase Therapeutics Inc 0.06 0.00% 0.00 % 0.00 %
Amgen Inc 45,369.00 51.38% 47.31% 46.23%
Gilead Sciences Inc 29,736.00 33.67% 36.72% 37.34%
Biogen Inc 9,937.40 11.25% 11.66% 12.23%
Halozyme Therapeutics Inc 1,508.46 1.71% 2.26% 2.02%
Acadia Pharmaceuticals Inc 1,095.25 1.24% 1.45% 1.44%
12 more competitors available

Sign in to see all competitors for Inhibikase Therapeutics Inc .

Sign In Create Free Account



IKT's Market share relative to its competitors, as of Q2 2026 within the Biotechnology & Pharmaceuticals Industry
As of Q2 2026



COMPANY NAME MARKET SHARE
12 Months Ending
Q2 2026		 MARKET SHARE
12 Months Ending
Q1 2026		 MARKET SHARE
MRQ
Q2 2026		 MARKET SHARE

Q1 2026
Inhibikase Therapeutics Inc 0.00% 0.00% 0.00 % 0.00 %
Amgen Inc 52.02% 44.73% 48.01% 46.91%
Gilead Sciences Inc 34.10% 39.41% 37.26% 37.89%
Biogen Inc 11.39% 13.24% 11.83% 12.41%
Halozyme Therapeutics Inc 1.73% 1.87% 2.30% 2.05%
Alvotech 0.68% 0.66% 0.68% 0.66%
9 more companies available

Sign in to see all industry competitors for Inhibikase Therapeutics Inc .

Sign In Create Free Account



IKT's Market share relative to its competitors, as of Q2 2026 within the Healthcare Sector
As of Q2 2026



COMPANY NAME MARKET SHARE
12 Months Ending
Q2 2026		 MARKET SHARE
12 Months Ending
Q1 2026		 MARKET SHARE
MRQ
Q2 2026		 MARKET SHARE

Q1 2026
Inhibikase Therapeutics Inc 0.00% 0.00% 0.00 % 0.00 %
Amgen Inc 51.38% 44.10% 47.31% 46.23%
Gilead Sciences Inc 33.67% 38.85% 36.72% 37.34%
Biogen Inc 11.25% 13.05% 11.66% 12.23%
Halozyme Therapeutics Inc 1.71% 1.84% 2.26% 2.02%
Acadia Pharmaceuticals Inc 1.24% 1.41% 1.45% 1.44%
12 more companies available

Sign in to see all sector competitors for Inhibikase Therapeutics Inc .

Sign In Create Free Account



Note: Market share is calculated based on total revenue. To get a more accurate picture of Inhibikase Therapeutics Inc's market divisions, geographic dispersion, segments, products, and services, visit Inhibikase Therapeutics Inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.